Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 425 of 1475 entries
View as:

A Taste Assessment of BMS-986165 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03751228 Org: User:
Start: 10/11/18 End: 11/26/18 Due: 11/26/19

A Phase I Study of BMS-690514 in Combination With Paclitaxel and Carboplatin

Phase: N/A Priority: Normal
NCT ID: NCT00420186 Org: User:
Start: 10/31/07 End: 02/29/12 Due: 02/28/13

A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06764771 Org: User:
Start: 03/25/25 End: 10/15/27 Due: 10/15/28

Safety Study of BMS-986165 in Healthy Subjects and to Treat Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02534636 Org: User:
Start: 10/31/15 End: 11/30/16 Due: 11/30/17

Non-Interventional Study (NIS) of Nivolumab With or Without Ipilimumab in Participants With Advanced Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03455452 Org: User:
Start: 01/21/18 End: 11/30/25 Due: 11/30/26

Atazanavir/Ritonavir, Once Daily + Raltegravir, Twice Daily, Switch Study in HIV-1-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT01332227 Org: User:
Start: 10/31/11 End: 02/28/14 Due: 02/28/15

A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs

Phase: N/A Priority: Normal
NCT ID: NCT00002411 Org: User:
Start: 03/31/98 End: 09/30/99 Due: 09/30/00

An Investigational Study to Assess the Effect of BMS-986177 on Aspirin in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03341390 Org: User:
Start: 10/18/17 End: 11/16/17 Due: 11/16/18

Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00384904 Org: User:
Start: 12/31/06 End: 12/31/07 Due: 12/31/08

Phase 1 Drug Interaction Study of Apixaban and Atenolol in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02262533 Org: User:
Start: 06/30/07 End: 06/30/07 Due: 06/30/08

A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)

Phase: N/A Priority: Normal
NCT ID: NCT01732848 Org: User:
Start: 11/30/12 End: 06/30/14 Due: 06/30/15

A Post-Authorization, Long-term Study of Ozanimod Real-world Safety

Phase: N/A Priority: Normal
NCT ID: NCT05605782 Org: User:
Start: 09/02/21 End: 07/26/33 Due: 07/26/34

A Study of the Effectiveness and Safety of Nivolumab Plus Chemotherapy in Participants With Untreated Advanced/Recurrent Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05334719 Org: User:
Start: 06/29/22 End: 09/30/26 Due: 09/30/27

An Investigational Study to Assess the Effect of a Light Meal and a High-Fat Meal on the Absorption of BMS-986205 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03312426 Org: User:
Start: 10/09/17 End: 11/22/17 Due: 11/22/18

A Study to Assess the Safety, Tolerability and Drug Levels of BMS-986172 in Healthy and Obese Participants, Including an Assessment of the Effects of Food on BMS-986172 Absorption

Phase: N/A Priority: Normal
NCT ID: NCT04926051 Org: User:
Start: 06/15/21 End: 12/28/21 Due: 12/28/22

A Study to Observe the Onset of Immune-related Adverse Reactions in Patients With Non-surgical or Renal Cell Carcinoma (RCC) That Has Spread

Phase: N/A Priority: Normal
NCT ID: NCT03663946 Org: User:
Start: 09/18/18 End: 05/30/20 Due: 05/30/21

A Study of Tanespimycin (KOS-953) in Patients With Relapsed-refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00514371 Org: User:
Start: 08/31/07 End: 02/28/09 Due: 02/28/10

Open-Label Study Comparing Efficacy and Safety of ATV/RTV+3TC With ATV/RTV+TDF/FTC in HIV-Infected, Treatment Naïve Subjects, Followed by Treatment With ATV/RTV+3TC

Phase: N/A Priority: Normal
NCT ID: NCT01620944 Org: User:
Start: 07/31/12 End: 01/22/13 Due: 01/22/14

A Study to Compare the Pharmacokinetics of Belatacept Using Active Pharmaceutical Ingredient Manufactured by Process E Relative to Process C

Phase: N/A Priority: Normal
NCT ID: NCT02564497 Org: User:
Start: 10/02/15 End: 01/27/17 Due: 01/27/18

CV004-007 Thrombosis Chamber Study

Phase: N/A Priority: Normal
NCT ID: NCT02439190 Org: User:
Start: 09/30/15 End: 03/31/16 Due: 03/31/17

Clinical and Economic Burden of Bleeding Events in Patients in the UK With Non-valvular Atrial Fibrillation Treated With Vitamin k Antagonists

Phase: N/A Priority: Normal
NCT ID: NCT02661516 Org: User:
Start: 07/31/14 End: 12/31/15 Due: 12/31/16

Real-Life Effectiveness and Safety in Participants With Advanced/Metastatic Renal Cell Carcinoma Starting 1st Line Nivolumab and Ipilimumab Combination Therapy or Nivolumab Monotherapy After Prior Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02940639 Org: User:
Start: 10/27/16 End: 12/15/25 Due: 12/15/26

Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kg

Phase: N/A Priority: Normal
NCT ID: NCT00705367 Org: User:
Start: 08/31/08 End: 07/31/11 Due: 07/31/12

Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV

Phase: N/A Priority: Normal
NCT ID: NCT01866930 Org: User:
Start: 07/11/13 End: 08/27/15 Due: 08/27/16

Real-World Use of Nivolumab for the Treatment of Patients With Metastatic Upper Gastrointestinal Cancer in Canada

Phase: N/A Priority: Normal
NCT ID: NCT06361576 Org: User:
Start: 09/05/23 End: 01/25/24 Due: 01/25/25